Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
lonafarnib | protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | small molecule | NA | drugbank , DGIDB | Homozygote[MeSHID:D006720] Body Surface Area[MeSHID:D001830] Progeria[MeSHID:D011371] Mutation[MeSHID:D009154] Heterozygote[MeSHID:D006579] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] MYELODYSPLASTIC SYNDROME[MeSHID:D009190] Non-Small Cell Lung Carcinoma[MeSHID:D002289] Hepatitis D Infection[MeSHID:D003699] |
15.91 | approved,investigational | inhibitor |
lonafarnib | protein farnesyltransferase subunit beta | small molecule | NA | drugbank , DGIDB | Homozygote[MeSHID:D006720] Body Surface Area[MeSHID:D001830] Progeria[MeSHID:D011371] Mutation[MeSHID:D009154] Heterozygote[MeSHID:D006579] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] MYELODYSPLASTIC SYNDROME[MeSHID:D009190] Non-Small Cell Lung Carcinoma[MeSHID:D002289] Hepatitis D Infection[MeSHID:D003699] |
6.37 | approved,investigational | inhibitor |
click here to return to the previous page |